Schroder Investment Management Group’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,325
| Closed | -$548K | – | 1244 |
|
|
2023
Q3 | $548K | Hold |
7,325
| – | – | ﹤0.01% | 1081 |
|
|
2023
Q2 | $675K | Buy |
+7,325
| New | +$652K | ﹤0.01% | 1092 |
|
|
2021
Q4 | – | Sell |
-13,468
| Closed | -$2.59M | – | 1470 |
|
|
2021
Q3 | $2.59M | Sell |
13,468
-45,459
| -77% | -$11.2M | ﹤0.01% | 920 |
|
|
2021
Q2 | $16.7M | Sell |
58,927
-35,403
| -38% | -$9.59M | 0.02% | 553 |
|
|
2021
Q1 | $20M | Sell |
94,330
-64,699
| -41% | -$15.5M | 0.03% | 504 |
|
|
2020
Q4 | $31.2M | Sell |
159,029
-29,241
| -16% | -$5.17M | 0.04% | 377 |
|
|
2020
Q3 | $31M | Buy |
188,270
+82,876
| +79% | +$13.6M | 0.05% | 343 |
|
|
2020
Q2 | $14.6M | Buy |
105,394
+26,152
| +33% | +$2.4M | 0.03% | 482 |
|
|
2020
Q1 | $5.04M | Buy |
79,242
+75,549
| +2,046% | +$6.88M | 0.01% | 668 |
|
|
2019
Q4 | $405K | Buy |
3,693
+2,893
| +362% | +$280K | ﹤0.01% | 1078 |
|
|
2019
Q3 | $81K | Sell |
800
-900
| -53% | -$96.7K | ﹤0.01% | 1207 |
|
|
2019
Q2 | $218K | Sell |
1,700
-5,865
| -78% | -$815K | ﹤0.01% | 1076 |
|
|
2019
Q1 | $965K | Buy |
7,565
+5,865
| +345% | +$744K | ﹤0.01% | 907 |
|
|
2018
Q4 | $213 | Hold |
1,700
| – | – | ﹤0.01% | 1078 |
|
|
2018
Q3 | $377K | Sell |
1,700
-7,500
| -82% | -$1.52M | ﹤0.01% | 1057 |
|
|
2018
Q2 | $1.45M | Hold |
9,200
| – | – | ﹤0.01% | 869 |
|
|
2018
Q1 | $860K | Sell |
9,200
-3,600
| -28% | -$269K | ﹤0.01% | 974 |
|
|
2017
Q4 | $893K | Sell |
12,800
-11,121
| -46% | -$738K | ﹤0.01% | 999 |
|
|
2017
Q3 | $1.43M | Sell |
23,921
-34,469
| -59% | -$1.72M | ﹤0.01% | 927 |
|
|
2017
Q2 | $2.41M | Buy |
58,390
+36,879
| +171% | +$1.6M | ﹤0.01% | 838 |
|
|
2017
Q1 | $944K | Sell |
21,511
-771
| -3% | -$33.2K | ﹤0.01% | 964 |
|
|
2016
Q4 | $928K | Buy |
22,282
+6,931
| +45% | +$279K | ﹤0.01% | 925 |
|
|
2016
Q3 | $580K | Buy |
15,351
+5,014
| +49% | +$180K | ﹤0.01% | 961 |
|
|
2016
Q2 | $344K | Sell |
10,337
-1,007
| -9% | -$32.5K | ﹤0.01% | 993 |
|
|
2016
Q1 | $340K | Buy |
+11,344
| New | +$332K | ﹤0.01% | 999 |
|
|
2015
Q1 | – | Sell |
-2,000
| Closed | -$67K | – | 1280 |
|
|
2014
Q4 | $67K | Sell |
2,000
-110,919
| -98% | -$3.45M | ﹤0.01% | 1188 |
|
|
2014
Q3 | $3.71M | Buy |
112,919
+24,200
| +27% | +$743K | ﹤0.01% | 825 |
|
|
2014
Q2 | $2.7M | Buy |
88,719
+74,700
| +533% | +$2.33M | ﹤0.01% | 848 |
|
|
2014
Q1 | $408K | Buy |
14,019
+700
| +5% | +$18.8K | ﹤0.01% | 1099 |
|
|
2013
Q4 | $348K | Hold |
13,319
| – | – | ﹤0.01% | 1174 |
|
|
2013
Q3 | $358K | Buy |
13,319
+1,600
| +14% | +$42.8K | ﹤0.01% | 1147 |
|
|
2013
Q2 | $302K | Buy |
+11,719
| New | +$308K | ﹤0.01% | 1170 |
|
Other funds holding MED
Schroder Investment Management Group's MED Position: Q4 2023 in Review
Schroder Investment Management Group sold out of Medifast (MED) in Q4 2023, closing a stake of 7,325 shares — an estimated $548K sold.
Schroder Investment Management Group first reported a position in MED in Q2 2013 and held it in 32 quarters. The position peaked at $31.2M in Q4 2020. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.
- Schroder Investment Management Group reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
- Schroder Investment Management Group sold 7,325 Medifast shares in Q4 2023, an estimated $548K.
- Schroder Investment Management Group first reported a position in Medifast in Q2 2013 and held it in 32 quarters.
- Schroder Investment Management Group's Medifast position peaked at $31.2M in Q4 2020.
- 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.
Based on Schroder Investment Management Group's 13F filing for Q4 2023, filed 14 Feb 2024.